Ameriprise Financial Inc. Sells 13,355 Shares of CRH plc (NYSE:CRH)

Ameriprise Financial Inc. reduced its holdings in shares of CRH plc (NYSE:CRH - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,722,772 shares of the construction company's stock after selling 13,355 shares during the quarter. Ameriprise Financial Inc. owned 0.40% of CRH worth $251,911,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Alyeska Investment Group L.P. bought a new stake in shares of CRH in the fourth quarter worth $13,604,000. Ancora Advisors LLC boosted its position in CRH by 3.4% in the fourth quarter. Ancora Advisors LLC now owns 187,422 shares of the construction company's stock worth $17,340,000 after purchasing an additional 6,229 shares during the last quarter. Armor Advisors L.L.C. grew its stake in shares of CRH by 27.3% during the 4th quarter. Armor Advisors L.L.C. now owns 302,886 shares of the construction company's stock valued at $28,023,000 after purchasing an additional 65,000 shares during the period. AXA S.A. increased its position in shares of CRH by 23.1% during the 4th quarter. AXA S.A. now owns 133,108 shares of the construction company's stock valued at $12,315,000 after purchasing an additional 24,944 shares during the last quarter. Finally, Advanced Portfolio Management LLC bought a new position in shares of CRH in the 4th quarter worth approximately $2,961,000. 62.50% of the stock is owned by hedge funds and other institutional investors.

CRH Stock Performance

Shares of CRH stock opened at $98.21 on Tuesday. CRH plc has a fifty-two week low of $71.18 and a fifty-two week high of $110.97. The company has a market cap of $66.42 billion, a P/E ratio of 19.64, a price-to-earnings-growth ratio of 1.15 and a beta of 1.33. The firm has a 50-day simple moving average of $91.94 and a two-hundred day simple moving average of $96.14.

CRH Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 23rd will be paid a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.51%. CRH's dividend payout ratio is currently 22.66%.

Analyst Ratings Changes

CRH has been the subject of several analyst reports. Loop Capital initiated coverage on CRH in a research note on Wednesday, April 9th. They issued a "buy" rating and a $114.00 price objective for the company. Berenberg Bank set a $120.00 price objective on CRH in a research report on Friday, February 28th. StockNews.com upgraded CRH from a "hold" rating to a "buy" rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. lowered their price target on shares of CRH from $118.00 to $114.00 and set an "overweight" rating on the stock in a report on Tuesday, March 11th. Finally, Citigroup reduced their price objective on shares of CRH from $120.00 to $115.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Eleven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $112.36.

CRH Profile

CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.